Filtros de búsqueda

Lista de obras de Nicoletta Testoni

'Fingerprinting' of HLA-DQA by polymerase chain reaction and heteroduplex analysis

scientific article published on 01 April 1996

4q12 translocations with GSX2 expression identify a CD7(+) acute myeloid leukaemia subset

article

A phase II study of alpha-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia.

artículo científico publicado en 2003

A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia

artículo científico publicado en 2002

A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients

artículo científico publicado en 2011

ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o

article by Simona Soverini et al published 20 June 2005 in Journal of Clinical Oncology

Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.

artículo científico publicado en 2006

Acute nonlymphocytic leukemias and dysmyelopoietic syndromes in patients treated for Hodgkin's lymphoma

scientific article published on 01 July 1983

Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: clinical implications

scientific article published on 12 May 2008

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.

artículo científico publicado en 2012

All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia

artículo científico publicado en 2000

Amplification of third-complementary-determining-region (CDR-III) of heavy chain immunoglobulin gene (IgH) in one hundred adult acute leukemias

artículo científico publicado en 1997

Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts

artículo científico publicado en 2003

Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods

artículo científico publicado en 1998

Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study

artículo científico publicado en 1999

B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.

artículo científico publicado en 2010

BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia

artículo científico publicado en 2013

Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase

artículo científico publicado en 1998

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.

artículo científico publicado en 2001

Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients

artículo científico publicado en 2007

Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies

artículo científico publicado en 1999

Chromosome 12 rearrangement with breakage at the p11 level in hematologic disorders: report of four cases

scientific article published on 01 February 1985

Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications

artículo científico publicado en 2010

Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative Study.

artículo científico publicado en 1987

Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation--results of a European cooperative study

artículo científico publicado en 1987

Chromothripsis in acute myeloid leukemia: biological features and impact on survival.

artículo científico publicado en 2018

Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up

artículo científico

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

artículo científico publicado en 2009

Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment

artículo científico publicado en 2006

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study

artículo científico publicado en 2009

Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities

Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.

artículo científico publicado en 2015

Concomitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient

scientific article published on 01 September 1999

Conjunctival and Limbal Transplantation From the Same Living-Related Bone Marrow Donor to Patients With Severe Ocular Graft-vs-Host Disease

artículo científico publicado en 2017

Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.

artículo científico publicado en 2013

Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy

artículo científico publicado en 2017

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation.

artículo científico publicado en 2003

Cytogenetic analyses in 89 patients with secondary hematologic disorders--results of a cooperative study

artículo científico publicado en 1987

Cytogenetic and molecular analyses in Philadelphia chromosome positive acute lymphoblastic leukaemia

artículo científico publicado en 1988

Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations

artículo científico publicado en 1989

Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia

artículo científico publicado en 1991

Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis

artículo científico publicado en 2010

Does the type of BCR/ABL junction predict the survival of patients with Ph1-positive chronic myeloid leukemia?

artículo científico publicado en 1995

Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia

artículo científico publicado en 2013

Efficacy of Azacitidine in the treatment of adult patients aged 65 years or older with AML.

artículo científico publicado en 2016

Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy.

artículo científico publicado en 2009

Epigenetically induced ectopic expression of UNCX impairs the proliferation and differentiation of myeloid cells

artículo científico publicado en 2017

Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation

artículo científico publicado en 2007

Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage

artículo científico publicado en 2002

FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features.

artículo científico publicado en 2016

FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case report

scientific article published on 01 February 1994

FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia

artículo científico publicado en 1996

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities

artículo científico publicado en 2014

Fingerprinting of HLA class I genes for improved selection of unrelated bone marrow donors

artículo científico publicado en 1996

Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients

artículo científico publicado en 1999

Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome

artículo científico publicado en 2008

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party

article by Gabriele Gugliotta et al published 26 May 2011 in Blood

Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia

artículo científico publicado en 2006

Granulocytic sarcomas: clinical, diagnostic and therapeutical aspects.

artículo científico publicado en 1997

Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia

scientific article published on 01 May 2004

Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia

artículo científico publicado en 2004

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party

artículo científico publicado en 2007

Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.

artículo científico publicado en 2002

Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications

artículo científico publicado en 1994

Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results

artículo científico publicado en 2009

Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis

artículo científico publicado en 1993

Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells

article

Inversions of chromosome 12 in human malignancies

scientific article published on 01 September 1987

Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy

artículo científico publicado en 2009

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.

artículo científico publicado en 2015

Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.

artículo científico publicado en 2008

Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib.

artículo científico publicado en 2011

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment

artículo científico publicado en 2015

Molecular analysis of PML-RAR alpha fusion mRNA detected by reverse transcription-polymerase chain reaction assay in long-term disease-free acute promyelocytic leukaemia patients

artículo científico publicado en 1995

Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia

artículo científico publicado en 2008

Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia

artículo científico publicado en 2005

Molecular and cytogenetic studies of a patient with Philadelphia-negative, BCR-positive chronic myeloid leukemia and t(12;12)(q13;p12)

artículo científico publicado en 1990

Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib

artículo científico publicado en 2009

Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma

artículo científico publicado en 2000

Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures

artículo científico publicado en 1999

Molecular response to imatinib in late chronic-phase chronic myeloid leukemia

artículo científico publicado en 2003

Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients

artículo científico publicado en 2005

Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.

artículo científico publicado en 2015

NPM1 mutations are more stable than FLT3 mutations during the course of disease in patients with acute myeloid leukemia

scientific article published on 01 September 2007

Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia

artículo científico publicado en 2009

Normal bone marrow karyotype in paroxysmal nocturnal hemoglobinuria--a cooperative European study

artículo científico publicado en 1983

Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.

artículo científico publicado en 2003

Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis

artículo científico publicado en 2016

Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patient with breast infiltration

artículo científico publicado en 2010

Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation

Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.

artículo científico publicado en 2013

Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia

artículo científico publicado en 2006

Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia

scientific article published on 27 May 2008

Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens

Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response

scientific article published on 01 September 2000

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

artículo científico publicado en 2002

Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome

artículo científico publicado en 2013

Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.

artículo científico publicado en 2009

Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study

artículo científico publicado en 2010

Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain

artículo científico publicado en 2007

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party

artículo científico publicado en 2009

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients

artículo científico publicado en 2015

Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.

artículo científico publicado en 1993

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

artículo científico publicado en 2005

The GNAS1 gene in myelodysplastic syndromes (MDS)

article

The cytogenetic response as a surrogate marker of survival

artículo científico publicado en 2003

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study

artículo científico publicado en 2007

The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up

artículo científico publicado en 2009

The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance

scientific article published on 01 July 1995

The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase

artículo científico publicado en 2010

The type of BCR/ABL junction does not predict the survival of patients with Ph1-positive chronic myeloid leukaemia

artículo científico publicado en 1993

Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)

scientific article published on 01 October 1999

Treatment of Ph+ chronic myeloid leukemia by gamma interferon.

artículo científico publicado en 1989

Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response

artículo científico publicado en 2009

Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.

artículo científico publicado en 1999

Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.

artículo científico publicado en 2011

Vimentin and keratin intermediate filaments expression by K562 leukemic cell line

artículo científico publicado en 1986

t(8;14)(q11;q32) in acute lymphoid leukemia: description of two cases.

artículo científico publicado en 1993

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda